Cetera Investment Advisers’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.34M | Buy |
24,391
+941
| +4% | +$206K | 0.01% | 1150 |
|
|
2025
Q1 | $5.25M | Buy |
23,450
+2,879
| +14% | +$645K | 0.01% | 1082 |
|
|
2024
Q4 | $6.74M | Buy |
20,571
+1,239
| +6% | +$406K | 0.01% | 888 |
|
|
2024
Q3 | $5.8M | Sell |
19,332
-49
| -0.3% | -$14.7K | 0.01% | 935 |
|
|
2024
Q2 | $6.38M | Buy |
19,381
+391
| +2% | +$129K | 0.01% | 870 |
|
|
2024
Q1 | $7.51M | Buy |
18,990
+15,952
| +525% | +$6.31M | 0.02% | 783 |
|
|
2023
Q4 | $1.07M | Buy |
3,038
+78
| +3% | +$27.5K | 0.01% | 1072 |
|
|
2023
Q3 | $1.11M | Sell |
2,960
-366
| -11% | -$137K | 0.01% | 1000 |
|
|
2023
Q2 | $1.27M | Buy |
3,326
+79
| +2% | +$30.2K | 0.01% | 962 |
|
|
2023
Q1 | $1.13M | Sell |
3,247
-114
| -3% | -$39.5K | 0.01% | 977 |
|
|
2022
Q4 | $791K | Buy |
3,361
+396
| +13% | +$93.2K | 0.01% | 1105 |
|
|
2022
Q3 | $730K | Sell |
2,965
-185
| -6% | -$45.5K | 0.01% | 840 |
|
|
2022
Q2 | $952K | Sell |
3,150
-1,714
| -35% | -$518K | 0.02% | 819 |
|
|
2022
Q1 | $2M | Buy |
4,864
+207
| +4% | +$85K | 0.03% | 562 |
|
|
2021
Q4 | $2.18M | Sell |
4,657
-956
| -17% | -$448K | 0.03% | 523 |
|
|
2021
Q3 | $2.38M | Buy |
5,613
+996
| +22% | +$423K | 0.04% | 463 |
|
|
2021
Q2 | $1.66M | Buy |
4,617
+2,332
| +102% | +$837K | 0.03% | 580 |
|
|
2021
Q1 | $644K | Sell |
2,285
-1,439
| -39% | -$406K | 0.01% | 848 |
|
|
2020
Q4 | $1.06M | Buy |
+3,724
| New | +$1.06M | 0.02% | 641 |
|